AU1272295A - Proinsulin-like compounds - Google Patents

Proinsulin-like compounds

Info

Publication number
AU1272295A
AU1272295A AU12722/95A AU1272295A AU1272295A AU 1272295 A AU1272295 A AU 1272295A AU 12722/95 A AU12722/95 A AU 12722/95A AU 1272295 A AU1272295 A AU 1272295A AU 1272295 A AU1272295 A AU 1272295A
Authority
AU
Australia
Prior art keywords
proinsulin
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU12722/95A
Inventor
Asser Andersen
Thomas Kjeldsen
Claus Kristensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK139993A external-priority patent/DK139993D0/en
Priority claimed from DK140093A external-priority patent/DK140093D0/en
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU1272295A publication Critical patent/AU1272295A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/65Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/72Receptors; Cell surface antigens; Cell surface determinants for hormones
AU12722/95A 1993-12-17 1994-12-16 Proinsulin-like compounds Abandoned AU1272295A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
DK139993A DK139993D0 (en) 1993-12-17 1993-12-17 PRODUCT
DK1399/93 1993-12-17
DK140093A DK140093D0 (en) 1993-12-17 1993-12-17 PRODUCT
DK1400/93 1993-12-17
DK029/94 1994-01-07
DK2994 1994-01-07
PCT/DK1994/000471 WO1995016708A1 (en) 1993-12-17 1994-12-16 Proinsulin-like compounds

Publications (1)

Publication Number Publication Date
AU1272295A true AU1272295A (en) 1995-07-03

Family

ID=27220342

Family Applications (1)

Application Number Title Priority Date Filing Date
AU12722/95A Abandoned AU1272295A (en) 1993-12-17 1994-12-16 Proinsulin-like compounds

Country Status (2)

Country Link
AU (1) AU1272295A (en)
WO (1) WO1995016708A1 (en)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0150565B1 (en) * 1995-02-15 1998-08-17 김정재 A process for preparing human proinsulin by recombinant dna technology
CA2223272A1 (en) * 1995-05-05 1996-11-07 Ronald Eugene Chance Single chain insulin with high bioactivity
US5622932A (en) * 1995-05-05 1997-04-22 Eli Lilly And Company IGF-1 superagonists
US7378390B2 (en) 1999-12-29 2008-05-27 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US6521738B2 (en) 1999-12-29 2003-02-18 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
DE60044728D1 (en) 1999-12-29 2010-09-02 Novo Nordisk As METHOD FOR THE PRODUCTION OF INSULIN FORECASTS AND ANALOGS OF INSULIN PROCESSORS WITH IMPROVED FERMENTATION EXPORTS IN YEAST
CN100432104C (en) * 1999-12-29 2008-11-12 诺沃挪第克公司 Method for making insulin precursors and insulin precursor analogs
US6777207B2 (en) 1999-12-29 2004-08-17 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
US7105314B2 (en) 2001-04-02 2006-09-12 Novo Nordisk A/S Method for making human insulin precursors
WO2002100887A2 (en) * 2001-06-08 2002-12-19 Novo Nordisk A/S Method for making insulin precursors and insulin precursor analogs
EP2261250B1 (en) 2001-12-21 2015-07-01 Human Genome Sciences, Inc. GCSF-Albumin fusion proteins
JP5697831B2 (en) * 2003-12-03 2015-04-08 ノヴォ ノルディスク アー/エス Single chain insulin
KR101729986B1 (en) 2006-09-22 2017-04-25 노보 노르디스크 에이/에스 Protease resistant insulin analogues
US8946148B2 (en) 2007-11-20 2015-02-03 Ambrx, Inc. Modified insulin polypeptides and their uses
BRPI1014760B8 (en) 2009-06-26 2021-05-25 Novo Nordisk As preparation comprising insulin, nicotinamide and arginine
WO2012080362A1 (en) 2010-12-14 2012-06-21 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and an amino acid
EP2651432A1 (en) 2010-12-14 2013-10-23 Novo Nordisk A/S Fast-acting insulin in combination with long-acting insulin
EP2768520A4 (en) 2011-10-18 2015-07-15 AmideBio LLC Chemically and thermodynamically stable insulin analogues and improved methods for their production
CN109180802A (en) * 2011-12-15 2019-01-11 爱德迪安(北京)生物技术有限公司 Compound, composition with hypoglycemic effect and application thereof
WO2013186138A1 (en) 2012-06-14 2013-12-19 Novo Nordisk A/S Preparation comprising insulin, nicotinamide and arginine
WO2014088836A1 (en) 2012-12-03 2014-06-12 Merck Sharp & Dohme Corp. O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
EP2986315A4 (en) 2013-04-17 2017-03-01 AmideBio LLC Chemically and thermodynamically stable insulin analogues and improved methods for their production
TW201605470A (en) 2013-10-04 2016-02-16 默沙東藥廠 Glucose-responsive insulin conjugates
GB201321489D0 (en) 2013-12-05 2014-01-22 Chemical & Biopharmaceutical Lab Of Patras S A Biologically active insulin derivatives
WO2016081670A2 (en) 2014-11-21 2016-05-26 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
WO2016144658A1 (en) 2015-03-10 2016-09-15 Merck Sharp & Dohme Corp. Process for preparing recombinant insulin using microfiltration
US10745457B2 (en) 2015-09-02 2020-08-18 Merck Sharp & Dohme Corp. Process for obtaining insulin with correctly formed disulfide bonds
WO2017189342A1 (en) 2016-04-26 2017-11-02 Merck Sharp & Dohme Corp. Insulin dimer-incretin conjugates
US10953076B2 (en) 2016-05-24 2021-03-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists and GLP-1 analogues
US10689430B2 (en) 2016-05-25 2020-06-23 Merck Sharp & Dohme Corp. Insulin receptor partial agonists
EP3272877A1 (en) 2016-07-18 2018-01-24 ETH Zurich B-cell-mimetic cells
JP2019520837A (en) 2016-07-18 2019-07-25 イーティーエイチ・チューリッヒ Sac cell mimetic cells
AU2017322552B2 (en) 2016-09-06 2021-12-02 Chemical & Biopharmaceutical Laboratories Of Patras S.A. Proinsulin derivatives
EP3600381A4 (en) 2017-03-23 2021-06-16 Merck Sharp & Dohme Corp. Glucose responsive insulin comprising a tri-valent sugar cluster for treatment of diabetes
KR20220121833A (en) 2019-12-30 2022-09-01 간 앤 리 파마슈티칼스 컴퍼니, 리미티드 insulin derivatives
BR112022013042A2 (en) 2019-12-30 2022-10-18 Gan & Lee Pharmaceuticals Co Ltd FORMULA B COMPOUND, PHARMACEUTICAL FORMULATION, PHARMACEUTICAL COMPOSITION, METHOD TO TREAT OR PREVENT HYPERGLYCEMIA, DIABETES AND/OR OBESITY

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
AU612141B2 (en) * 1987-02-25 1991-07-04 Novo Nordisk A/S Novel insulin derivatives
ES2061797T3 (en) * 1988-06-23 1994-12-16 Hoechst Ag MINI-PROINSULIN, ITS PREPARATION AND EMPLOYMENT.
ATE93238T1 (en) * 1988-07-20 1993-09-15 Novo Nordisk As HUMAN INSULIN PLANTS AND PREPARATIONS THEREOF.
US5158875A (en) * 1989-08-25 1992-10-27 Amgen Inc. Production of biologically active insulin-like growth factor i from high expression host cell systems
WO1993023067A1 (en) * 1992-05-08 1993-11-25 Thomas Jefferson University Igf-1 analogs

Also Published As

Publication number Publication date
WO1995016708A1 (en) 1995-06-22

Similar Documents

Publication Publication Date Title
AU1272295A (en) Proinsulin-like compounds
AU6971794A (en) Novel compounds
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU6710294A (en) Tetrahydro-beta-carbolines
AU6705294A (en) Tetrahydro-pyrido-indole
AU3803593A (en) Compounds
AU7220794A (en) Detergent-package combination
AU5261093A (en) Aminoalkylphenyl compounds
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
AU1274295A (en) Heteroarylpyrroles
AU6389494A (en) Tv-projector
AU8104694A (en) Bagbottle
AU3048492A (en) New compounds
AU5394594A (en) New compounds
AU6971594A (en) Cyclobutylazoles
AU6427194A (en) Aza-androstane-17beta -carboxamides
AU3696093A (en) Aquamate
AU7285994A (en) Suncap
AU5780894A (en) Crankhead
AU3759793A (en) Compounds
AU6169294A (en) 15-oxasterols as hypocholesterolemics
AU6044594A (en) 5-aminoacetylaminosulfonanilide compound
AU5979694A (en) Depsidone compound